@article{1732bd9b3bdc4558b4b74e572005a4f9,
title = "Development of migrating tendon-bone attachments involves replacement of progenitor populations",
abstract = "Tendon-bone attachment sites, called entheses, are essential for musculoskeletal function. They are formed embryonically by Sox9+ progenitors and continue to develop postnatally, utilizing Gil1 lineage cells. Despite their importance, we lack information on the transition from embryonic to mature enthesis and on the relation between Sox9+ progenitors and the Gil1 lineage. Here, by performing a series of lineage tracing experiments in mice, we identify the onset of Gil1 lineage contribution to different entheses. We show that Oil expression is regulated embryonically by SHH signaling, whereas postnatally it is maintained by IHH signaling. During bone elongation, some entheses migrate along the bone shaft, whereas others remain stationary. Interestingly, in stationary entheses Sox9(+) cells differentiate into the Gil1 lineage, but in migrating entheses this lineage is replaced by Gil1 lineage. These Gli1(+) progenitors are defined embryonically to occupy the different domains of the mature enthesis. Overall, these findings demonstrate a developmental strategy whereby one progenitor population establishes a simple embryonic tissue, whereas another population contributes to its maturation. Moreover, they suggest that different cell populations may be considered for cell-based therapy of enthesis injuries.",
author = "Neta Felsenthal and Sarah Rubin and Tomer Stern and Sharon Krief and Deepanwita Pal and Pryce, {Brian A.} and Ronen Schweitzer and Elazar Zelzer",
note = "We thank Nitzan Konstantin for expert editorial assistance, Dr Ron Rotkoff for his help with statistical analysis and Dr Patrick Tschopp from the Clifford J. Tabin Lab at the Harvard Medical School for his assistance in generating Shh KO mice. Special thanks to all members of the Zelzer Laboratory for encouragement and advice. Conceptualization: N.F., E.Z.; Software: T.S.; Formal analysis: N.F., T.S.; Investigation: N.F.; Resources: S.R., S.K., D.P., B.A.P., R.S.; Writing - original draft: N.F., E.Z.; Writing - review & editing: N.F., E.Z.; Visualization: N.F.; Supervision: E.Z.; Project administration: E.Z.; Funding acquisition: E.Z. This study was supported by grants from the National Institutes of Health (R01 AR055580) and the European Research Council (310098, and Proof of Concept grant 737473). It was also supported by the Weizmann Institute of Science, through the following funders: the Jeanne and Joseph Nissim Foundation for Life Sciences Research, the Y. Leon Benoziyo Institute for Molecular Medicine, Beth Rom-Rymer, the Estate of David Levinson, the Bernard M. and Audrey Jaffe Foundation, the Georges Lustgarten Cancer Research Fund, the David and Fela Shapell Family Center for Genetic Disorders, the David and Fela Shapell Family Foundation INCPM Fund for Preclinical Studies, and the Estate of Bernard Bishin for the Weizmann Institute of Science-Clalit Program. Deposited in PMC for release after 12 months.",
year = "2018",
month = dec,
day = "18",
doi = "10.1242/dev.165381",
language = "الإنجليزيّة",
volume = "145",
journal = "Development",
issn = "0950-1991",
publisher = "Company of Biologists Ltd",
number = "24",
}